Carr, "The Effect of Anit-Inflammatory Drugs on Increased Vascular Permeability Induced by Chemical Mediators," The Journal of Pathology, vol. 108 (1), (1972) pp. 1-14. |
Calixto et al, "Nonpeptide Bradykinin Antagonists", (1991), pp. 97-129 The Journal of Pathology, vol. 108 (1), pp. 1-14 (1972). |
Cheronis et al, "Bradykinin antagonists: Synthesis and in vitro Activity of Bissuccinimidoalkane Peptide Dimers" Recent Progress on Kinins, (1992) pp. 551-558. |
Whalley et al., `Novel Peptide Heterodimers Withactions At BK2 And Either u Opioid, NK1 Or NK2 Receptors: In Vitro Studies`, British Journal of Pharmacology, vol. 109, Suppl., 19P, Jul. 1993. |
Vaverk et al., `Suyccinyl Bis-Bradykinins: Potent Agonists with Exceptional Resistance to Enzymatic Degradation`, Peptide: Struc. and Func., Proceedings of the 8th Amer. Pept. Symp., Pierce Chem. Co., Rockford, IL, pp. 381-384 1983. |
Stewart et al., Bradykinin Chemistry: Agonists and Antagonist, Advances in Experimental Medicine and Biology, Plenum Press, NY, NY pp. 585-589 1983. |
Calixto et al., `Nonpeptide Bradykinin Antagonist`, Bradykinin Antagonists: Basic and Clinical Research, Ronald Burch (Ed.), Marcel Dekker Inc., NY, NY, pp. 97-129 1991. |
Kodama et al., `Dimerization of neurokinin A and B COOH- terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes`, European Journal of Pharmacology, 151, pp. 317-320 1988. |